Also, our findings support previous data that WT1 expression levels have prognostic value in patients with APL on overall survival of responders to induction therapy and the determination of expression levels of WT1 might contribute to risk stratification in the future (Hecht et al., 2015). This evidence concerns the gene WT1 and acute promyelocytic leukemia.